Evogene Schedules Second Quarter 2025 Financial Results Release
29 juli, 13:00
29 juli, 13:00
Evogene Schedules Second Quarter 2025 Financial Results Release
PR Newswire
REHOVOT, Israel, July 29, 2025
Zoom conference call scheduled for August 19, 2025 , 9:00 AM ET
REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday, August 19, 2025 .
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time ( 4:00 PM Israel time).
To attend the conference, please register in advance:
https://www.veidan-conferencing.com/evogene
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost AI , ChemPass AI and GeneRator AI . Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes ( MicroBoost AI ), small molecules ( ChemPass AI ), and genetic elements ( GeneRator AI ).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its subsidiaries, including:
For more information, please visit: www.evogene.com .
Contact:
ir@evogene.com
Tel: +972-8-9311901
Logo: https://mma.prnewswire.com/media/1947468/4576969/Evogene_Logo.jpg
SOURCE Evogene
29 juli, 13:00
Evogene Schedules Second Quarter 2025 Financial Results Release
PR Newswire
REHOVOT, Israel, July 29, 2025
Zoom conference call scheduled for August 19, 2025 , 9:00 AM ET
REHOVOT, Israel , July 29, 2025 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2025, on Tuesday, August 19, 2025 .
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time ( 4:00 PM Israel time).
To attend the conference, please register in advance:
https://www.veidan-conferencing.com/evogene
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost AI , ChemPass AI and GeneRator AI . Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes ( MicroBoost AI ), small molecules ( ChemPass AI ), and genetic elements ( GeneRator AI ).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its subsidiaries, including:
For more information, please visit: www.evogene.com .
Contact:
ir@evogene.com
Tel: +972-8-9311901
Logo: https://mma.prnewswire.com/media/1947468/4576969/Evogene_Logo.jpg
SOURCE Evogene
Handelskrig
Apple
Analys
Handelskrig
Apple
Analys
1 DAG %
Senast
Kempower
Igår, 12:28
Laddat för tillväxt i Kempower
OMX Stockholm 30
1 DAG %
Senast
2 533,59